The mechanism underlying the effects of CerS-2 on breast cancer cells was associated with the decrease of the V-ATPase activity and extracellular hydrogen ion concentration [34], which can cause the inactivation of secreted MMP-2 and non-degradation of ECM [35,36], and ultimately accelerate the breast tumor’s invasion and metastasis. This evidence concerns the gene CERS2 and breast carcinoma.